Steps to redressing an imbalance: GLP-1 analogues for obesity in east Asia

Lancet Diabetes Endocrinol. 2022 Mar;10(3):153-154. doi: 10.1016/S2213-8587(22)00038-9. Epub 2022 Feb 4.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Asia, Eastern / epidemiology
  • Glucagon-Like Peptide 1*
  • Humans
  • Hypoglycemic Agents*
  • Obesity / epidemiology

Substances

  • Hypoglycemic Agents
  • Glucagon-Like Peptide 1